These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10884515)

  • 21. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narcotics and diabetes. II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics. Mechanism of diabetes: morphine interaction.
    Simon GS; Borzelleca J; Dewey WL
    J Pharmacol Exp Ther; 1981 Aug; 218(2):324-9. PubMed ID: 6114167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumatriptan effects on morphine-induced antinociceptive tolerance and physical dependence: The role of nitric oxide.
    Hassanipour M; Rajai N; Rahimi N; Fatemi I; Jalali M; Akbarian R; Shahabaddini A; Nazari A; Amini-Khoei H; Dehpour AR
    Eur J Pharmacol; 2018 Sep; 835():52-60. PubMed ID: 30016663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
    Williams J; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive effects of morphine were different between experimental and genetic diabetes.
    Takeshita N; Yamaguchi I
    Pharmacol Biochem Behav; 1998 Aug; 60(4):889-97. PubMed ID: 9700973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain.
    Sounvoravong S; Nakashima MN; Wada M; Nakashima K
    Eur J Pharmacol; 2004 Jan; 484(2-3):217-23. PubMed ID: 14744606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of intestinal P-glycoprotein increases the analgesic effects of oral morphine in a streptozotocin-induced diabetic mouse model.
    Nawa A; Fujita-Hamabe W; Kishioka S; Tokuyama S
    Drug Metab Pharmacokinet; 2011; 26(6):584-91. PubMed ID: 21878740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
    Zarrindast MR; Asgari-Afshar A; Sahebgharani M
    Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
    Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of diabetes on the antinociceptive effect of beta-endorphin.
    Kamei J; Kawashima N; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Brain Res; 1993 Aug; 619(1-2):76-80. PubMed ID: 8374794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Altered intestinal P-glycoprotein expression levels affect pharmacodynamics under diabetic condition].
    Nawa A; Fujita-Hamabe W; Kisioka S; Tokuyama S
    Yakugaku Zasshi; 2012; 132(2):161-6. PubMed ID: 22293693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cyclosporin A on morphine tolerance and dependence: involvement of L-arginine/nitric oxide pathway.
    Homayoun H; Khavandgar S; Namiranian K; Dehpour AR
    Eur J Pharmacol; 2002 Sep; 452(1):67-75. PubMed ID: 12323386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide attenuates the development and expression of antinociceptive tolerance to μ-opioid agonist morphine through l-arginine-iNOS and nitric oxide pathway.
    Khan MI; Ostadhadi S; Mumtaz F; Momeny M; Moghaddaskho F; Hassanipour M; Ejtemaei-Mehr S; Dehpour AR
    Biomed Pharmacother; 2017 Jan; 85():493-502. PubMed ID: 27899254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice.
    Kamei J; Kawai K; Mizusuna A; Saitoh A; Morita K; Narita M; Tseng LF; Nagase H
    Eur J Pharmacol; 1997 Mar; 322(1):27-30. PubMed ID: 9088866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse.
    Wu HE; Hong JS; Tseng LF
    Eur J Pharmacol; 2007 Oct; 571(2-3):145-51. PubMed ID: 17617400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of neuronal nitric oxide synthase attenuates the development of morphine tolerance in rats.
    Santamarta MT; Ulibarri I; Pineda J
    Synapse; 2005 Jul; 57(1):38-46. PubMed ID: 15858834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
    Haghparast A; Gheitasi IP; Lashgari R
    Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test.
    Granados-Soto V; Rufino MO; Gomes Lopes LD; Ferreira SH
    Eur J Pharmacol; 1997 Dec; 340(2-3):177-80. PubMed ID: 9537812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice.
    Gul H; Yildiz O; Dogrul A; Yesilyurt O; Isimer A
    Pain; 2000 Dec; 89(1):39-45. PubMed ID: 11113291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.